We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOCO
2376
DELISTED
GoHealth
GOCO
| $410K | ﹤0.01% |
+2,098
| New | +$505K |
|
|
LAND
2377
Gladstone Land Corp
LAND
$360M
| $410K | ﹤0.01% |
27,307
-3,850
| -12% | -$60.2K |
|
2378
Dime Commercial Bancshares
DCOM
$1.78B
| $409K | ﹤0.01% |
23,477
-5,800
| -20% | -$111K |
|
2379
Neurogene
NGNE
$712M
| $409K | ﹤0.01% |
1,702
-90
| -5% | -$21.8K |
|
2380
Forestar Group
FOR
$1.51B
| $408K | ﹤0.01% |
23,069
-4,736
| -17% | -$82.3K |
|
|
AKCA
2381
DELISTED
Akcea Therapeutics Inc
AKCA
| $408K | ﹤0.01% |
22,512
-3,160
| -12% | -$44.8K |
|
2382
Mercantile Bank Corp
MBWM
$1.05B
| $406K | ﹤0.01% |
22,505
-8,104
| -26% | -$170K |
|
2383
Q32 Bio
QTTB
$464M
| $406K | ﹤0.01% |
2,106
-275
| -12% | -$61.6K |
|
|
ACCD
2384
DELISTED
Accolade Inc
ACCD
| $406K | ﹤0.01% |
+10,443
| New | +$360K |
|
|
AKRO
2385
DELISTED
Akero Therapeutics
AKRO
| $404K | ﹤0.01% |
13,130
+1,684
| +15% | +$58.9K |
|
2386
XPEL
XPEL
$1.38B
| $404K | ﹤0.01% |
15,477
-1,357
| -8% | -$29.2K |
|
2387
Phathom Pharmaceuticals
PHAT
$692M
| $400K | ﹤0.01% |
10,920
-1,870
| -15% | -$64.8K |
|
2388
Talos Energy
TALO
$2.4B
| $399K | ﹤0.01% |
61,881
+1,385
| +2% | +$10.2K |
|
2389
OneSpaWorld
OSW
$2.66B
| $398K | ﹤0.01% |
61,167
-10,591
| -15% | -$64.4K |
|
2390
UFP Technologies
UFPT
$2.43B
| $398K | ﹤0.01% |
9,611
-1,463
| -13% | -$63.2K |
|
2391
Goldgroup Mining Inc.
GORO
$191M
| $397K | ﹤0.01% |
116,526
-17,359
| -13% | -$70.7K |
|
2392
Scholar Rock
SRRK
$6.44B
| $397K | ﹤0.01% |
22,436
-3,935
| -15% | -$58.5K |
|
|
SYRS
2393
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $397K | ﹤0.01% |
4,489
-403
| -8% | -$45.8K |
|
2394
Annexon
ANNX
$886M
| $396K | ﹤0.01% |
+13,116
| New | +$308K |
|
2395
Zentalis Pharmaceuticals
ZNTL
$302M
| $396K | ﹤0.01% |
12,110
-1,031
| -8% | -$36.1K |
|
2396
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $394K | ﹤0.01% |
25,706
+2,424
| +10% | +$45.5K |
|
2397
Lifecore Biomedical
LFCR
$190M
| $394K | ﹤0.01% |
40,552
-6,152
| -13% | -$58.6K |
|
2398
VSE Corp
VSEC
$6.12B
| $394K | ﹤0.01% |
12,868
-1,895
| -13% | -$56K |
|
2399
Financial Institutions
FISI
$821M
| $393K | ﹤0.01% |
25,549
-3,403
| -12% | -$55.9K |
|
2400
KALA BIO
KALA
$14.5M
| $393K | ﹤0.01% |
21
-3
| -13% | -$69K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.